NCT01284868View on ClinicalTrials.gov

A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy VolunteersPharmacodynamics of Mirabegron
Interventions
DRUG

mirabegron

oral

DRUG

Bisoprolol

oral

DRUG

propranolol

oral

DRUG

placebo

oral

Trial Locations (1)

75015

Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY